Solid operational aspects post-COVID, BMHS saw profit surge of nearly 200%
26 Aug 2024 11:08
As of June 2024, PT Bundamedik Tbk (BMHS) reported slight increase in revenue of 9% year-on-year (yoy) compared to H1 2021.
COVID-19 crisis subsides, Diagnos Lab eyes 2023 realistically
19 Jun 2023 11:49
PT Diagnos Laboratorium Utama Tbk (DGNS), a clinical laboratory service provider under Bundamedik Group, is anticipating the decline in its revenue and profit post COVID-19 crisis.
